Zotepine

佐替平

Report date: 2022/03/23 17:09:38
NME

Base Information

Drug NameZotepine
Drug Alias Name佐太平佐特平唑替平LodopinZoleptil +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsSerotonin 2c (5-HT2c) receptor antagonistsHistamine H1 receptor antagonists +[5] 
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 2c (5-HT2c) receptorHistamine H1 receptor +[5] 
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1981/12/07
Country/TerritoryGermanyJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN05AX11
Related LinksWikipediaDrugBankKEGG